Results 191 to 200 of about 355,010 (330)
Iron improves the antiviral activity of NK cells. [PDF]
Schimmer S+11 more
europepmc +1 more source
Objective Cutaneous lupus erythematosus (CLE) is an inflammatory skin manifestation of systemic lupus erythematosus. Type I interferons (IFNs) promote inflammatory responses and are elevated in CLE lesions. We recently reported that CLE lesions are frequently colonized with Staphylococcus aureus.
Lisa Abernathy‐Close+9 more
wiley +1 more source
Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas. [PDF]
Betz UAK+15 more
europepmc +1 more source
Enhancement of activity against influenza viruses by combinations of antiviral agents [PDF]
Frederick G. Hayden+2 more
openalex +1 more source
ABSTRACT Among autistic individuals, a subphenotype of disproportionate megalencephaly (ASD‐DM) seen at three years of age is associated with co‐occurring intellectual disability and poorer prognoses later in life. However, many of the genes contributing to ASD‐DM have yet to be delineated. In this study, we identified additional ASD‐DM candidate genes
Sierra S. Nishizaki+10 more
wiley +1 more source
Antiviral activity of eicosapentaenoic acid against zika virus and other enveloped viruses. [PDF]
Feng Y+10 more
europepmc +1 more source
ABSTRACT Macrocyclic calix[n]arenes have many applications, with diverse structures that can easily be functionalized either on upper or lower rims, mostly to impart solubility and improve biological activities. In this study, triazole‐based p‐tert‐butylcalix[4]arene conjugates (AT10a and AT10b) and their p‐tert‐butylphenol analogs (AT10b and AT11b ...
Alfred Ngenge Tamfu+2 more
wiley +1 more source
Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts [PDF]
Joseph M. Colacino, Carlos López
openalex +1 more source
Aims This review aimed to synthesise the evidence related to the incidence of serious and non‐serious adverse events with the use of monoclonal antibodies (mAbs) among COVID‐19 patients. Methods Databases were searched from January 2020 to September 2023 for randomized clinical trials (RCTs) that used mAbs for the treatment of COVID‐19 regardless of ...
Htet Htet+6 more
wiley +1 more source
Structural insights into tecovirimat antiviral activity and poxvirus resistance. [PDF]
Vernuccio R+17 more
europepmc +1 more source